Mouna Sawan

Mouna Sawan

Auto-generated profile, based on publicly available information

Mouna Sawan

School of Pharmacy, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2020 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
MSMouna Sawan
Mouna Sawan
EREmily Reeve
Emily Reeve
JTJustin Turner
Justin Turner
ATAdam Todd
Adam Todd
MSMichael A. Steinman
Michael A. Steinman
DGDanijela Gnjidic
Danijela Gnjidic
Introduction: There is increasing recognition of the need for deprescribing of inappropriate medications in older adults. However, efforts to encourage implementation of deprescribing in clinical practice have resulted in mixed results across settings and countries. Area covered: Searches were conducted in PubMed, Embase and Google Scholar in June 2019. Reference lists, citation checking, and personal reference libraries were also utilised. Studies capturing the main challenges of, and opportunities for, implementing deprescribing into clinical practice across selected health care settings internationally, and international deprescribing-orientated policies were included and summarised in this narrative review. Expert Opinion: Deprescribing intervention studies are inherently heterogeneous because of the complexity of interventions employed and often do not reflect the real-world. Further research investigating enhanced implementation of deprescribing into clinical practice and across health care settings is required. Process evaluations in deprescribing intervention studies are needed to determine the contextual factors that are important to the translation of the interventions in the real-world. Deprescribing interventions may need to be individually tailored to target the unique barriers and opportunities to deprescribing in different clinical settings. Introduction of national policies to encourage deprescribing may be beneficial, but need to be evaluated to determine if there are any unintended consequences.

1 May 2017 in Research in Social and Administrative Pharmacy
Verified
Journal Article
Closed access
MSMouna Sawan
Mouna Sawan
YJYun-Hee Jeon
Yun-Hee Jeon
RFRomano A. Fois
Romano A. Fois
TCTimothy F. Chen
Timothy F. Chen

11 December 2018 in Drugs & Aging
Verified
Journal Article
Closed access
PDF file
SHStephanie L. Harrison
Stephanie L. Harrison
MCMonica Cations
Monica Cations
TJTiffany Jessop
Tiffany Jessop
SHSarah N. Hilmer
Sarah N. Hilmer
MSMouna Sawan
Mouna Sawan
HBHenry Brodaty
Henry Brodaty

22 September 2020 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
LOLisa Kouladjian O'DOnnell
Lisa Kouladjian O'DOnnell
DGDanijela Gnjidic
Danijela Gnjidic
MSMouna Sawan
Mouna Sawan
EREmily Reeve
Emily Reeve
PKPatrick J. Kelly
Patrick J. Kelly
SHSarah N. Hilmer
Sarah N. Hilmer

15 February 2021 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Closed access
PDF file
MSMouna J. Sawan
Mouna J. Sawan
YJYun‐Hee Jeon
Yun‐Hee Jeon
CBChristine Bond
Christine Bond
SHSarah N. Hilmer
Sarah N. Hilmer
TCTimothy F. Chen
Timothy F. Chen
DGDanijela Gnjidic
Danijela Gnjidic

19 August 2021 in Expert Review of Clinical Pharmacology
Verified
Journal Article
Closed access
MSMouna J Sawan
Mouna J Sawan
DMDaniela C. Moga
Daniela C. Moga
MMMegan J. Ma
Megan J. Ma
JNJoanna C. Ng
Joanna C. Ng
KJKristina Johnell
Kristina Johnell
DGDanijela Gnjidic
Danijela Gnjidic
Introduction:Mitigating the burden of unnecessary polypharmacy or multiple medication use in people living with dementia has been recognized as a key priority internationally. One approach to reducing inappropriate polypharmacy is through medication withdrawal or deprescribing. Area covered:Non-systematic searches of key databases including PubMed, Embase, and Google Scholar were conducted from inception to 28 February 2021 for articles that assessed the safety and/or efficacy of deprescribing in older adults living with dementia. Personal reference libraries were also utilized. Information on current clinical trials was found in clinicaltrial.gov. Expert Opinion: There is limited direct evidence to inform deprescribing in older adults with dementia specifically. This review identified nineteen studies that have assessed the impact of deprescribing interventions to reduce inappropriate polypharmacy or direct deprescribing of specific medications. However, the current evidence is limited in scope as most studies focused on medication-related outcomes (e.g. discontinuation of high-risk medications) rather than patient-centered outcomes in individuals living with dementia. Furthermore, most studies focused on addressing inappropriate polypharmacy in older adults with dementia living in long-term care facilities, and interventions did not involve the person and their carer. Further evidence on the impact of deprescribing in this population across clinical settings is needed.